M. Snee

发表

Methods and basic data of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria.

M. Gardner, A. Hall, J. Terrell, 1990, BMJ.

Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria.

A J Hall, M J Gardner, M. Gardner, 1990, BMJ.

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

J. Peto, T. Treasure, D. Landau, 2011, The Lancet. Oncology.

The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study

J. Peto, T. Treasure, D. Landau, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation.

K. Franks, M. Callister, S. Vaidyanathan, 2014, Clinical lung cancer.

Bevacizumab in non-small cell lung cancer: an overview of practice in the era of molecular testing.

M. Snee, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Aggressive management of non-small cell lung cancer with synchronous solitary brain metastasis.

N. Vasudev, B. Crosse, J. Joffe, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis

K. Franks, M. Callister, A. Brunelli, 2019, European Respiratory Journal.

Assessment of factors influencing the outcome of radiotherapy for bladder cancer.

S. Davidson, R. Symonds, M. Snee, 1990, British journal of urology.

Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.

A. Hackshaw, R. Rudd, N. Gower, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative

J. Penrod, G. Hall, J. O'donnell, 2021, BMJ Open.

Brain metastases from carcinoma of breast: a review of 90 cases.

G. Kerr, A. Rodger, M. Snee, 1985, Clinical radiology.

Routine follow-up of breast cancer patients.

M. Snee, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.

K. Franks, L. Murray, S. Hinsley, 2016, The British journal of radiology.

SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection

R. Booton, W. Gregory, C. Faivre-Finn, 2020, European Respiratory Journal.

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

A. Bezjak, J. V. van Meerbeeck, C. Faivre-Finn, 2017, The Lancet. Oncology.

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.

W. Ryder, R. Rintoul, C. Faivre-Finn, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

R. Booton, R. Rintoul, C. Faivre-Finn, 2016, BMJ Open.

O-154 Impact of maintaining Hb with epoetin alfa on time toprogression (TTP), overall survival (OS), quality of life (QOL) and transfusion reduction in limited disease SCLC patients

A. Bezjak, G. Perry, Colum J Smith, 2005 .

Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer.

C. Faivre-Finn, A. Price, S. Erridge, 2012, Lung cancer.

Guidelines on the radical management of patients with lung cancer

K. Kerr, C. Faivre-Finn, C. Warburton, 2010, Thorax.

SOCCAR: Sequential or concurrent chemotherapy and hypofractionated accelerated radiotherapy in inoperable stage III NSCLC.

N. O'Rourke, R. McMenemin, C. Peedell, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CONVERT: An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS).

A. Bezjak, C. Faivre-Finn, P. Lorigan, 2016 .

Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and goo

A. Bezjak, C. Faivre-Finn, P. Lorigan, 2016, BMJ Open.

Metastatic carcinoma from unknown primary site: the experience of a large oncology centre.

M. Snee, N. Vyramuthu, 1985, The British journal of radiology.

Prophylactic cranial irradiation in extensive small-cell lung cancer.

L. Collette, P. Postmus, C. Faivre-Finn, 2007, The New England journal of medicine.

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

A. Nicholson, M. Parmar, D. Girling, 2008, The Lancet.

Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer.

P. Ellis, A. Hackshaw, T. Buchler, 2008, Lung cancer.

A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1).

N Thatcher, R. Booton, D. Dunlop, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Longstanding Challenges in Lung Cancer: Are We Meeting Them?

M. Snee, M. Hatton, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Single-agent mitomycin for advanced non-small cell lung cancer.

M. Snee, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Follow-up of women treated for breast cancer.

M. Snee, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.

Andrew Bottomley, Suresh Senan, Corinne Faivre-Finn, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status.

N. O'Rourke, R. McMenemin, C. Peedell, 2014, European journal of cancer.

The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of cervix.

S. Kaye, R. Symonds, M. Snee, 1989, British Journal of Cancer.

18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial

C. Faivre-Finn, I. Locke, P. Julyan, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative

J. Penrod, G. Hall, M. Daumont, 2021, BMJ Open.

The MARS feasibility trial : Conclusions not supported by data - Authors' reply

J. Peto, T. Treasure, D. Landau, 2011 .

OA13.01 The Impact of [18F]fludeoxyglucose PET/CT in Small-Cell Lung Cancer: Analysis of the Phase 3 CONVERT Trial

C. Faivre-Finn, I. Locke, P. Julyan, 2018, Journal of Thoracic Oncology.

Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort.

K. Franks, L. Murray, S. Ramasamy, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

53 Principal results of the feasibility phase of the Mesothelioma and Radical Surgery trial (MARS-feasibility)

J. Peto, T. Treasure, J. Bliss, 2011 .

Stereotactic ablative body radiotherapy for lung cancer.

K. Franks, P. Jain, M. Snee, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Traditional phase 1 and 2 studies in thoracic radiation oncology should be abandoned.

C. Faivre-Finn, M. Snee, 2014, International journal of radiation oncology, biology, physics.

FEASIBILITY PHASE OF THE MESOTHELIOMA AND RADICAL SURGERY (MARS) RANDOMISED CONTROLLED TRIAL COMPARING EXTRA-PLEURAL PNEUMONECTOMY (EPP) WITH NO EPP IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA

J. Peto, T. Treasure, D. Landau, 2011 .

S95 SOCCAR: Internationally Resonant Results from a Randomised Trial Based on UK Clinical Practise

N. O'Rourke, C. Peedell, M. Snee, 2012, Thorax.

Improving survival with thoracic radiotherapy in patients with small cell lung cancer. The CONVERT and the REST Trials.

C. Faivre-Finn, P. Lorigan, F. Blackhall, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

J. Peto, T. Treasure, D. Landau, 2011, The Lancet. Oncology.

Technique of radical postoperative radiotherapy after pneumonectomy for mesothelioma.

M. Snee, J. Lilley, 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

P2.16-16 SABRTOOTH: A Fasibility Study of SABR Versus Surgery in Patients with Peripheral Stage I NSCLC Considered to be at Higher Risk for Surgery

R. Booton, W. Gregory, C. Faivre-Finn, 2018, Journal of Thoracic Oncology.

Prophylactic Cranial Irradiation (PCI) in Extensive Stage Small Cell Lung Cancer (ES-SCLC) (EORTC 22993-08993)

L. Collette, P. Postmus, M. Mauer, 2007 .

A randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a response to chemotherapy (EORTC 08993–22993)

L. Collette, C. Faivre-Finn, S. Senan, 2007 .

Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.

P. Baas, J. Penrod, H. Ubhi, 2021, Lung cancer.

A randomized phase III trial of active symptom control (ASC) with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma: First results of the Medical Research Council (MRC) / British Thoracic Society (BTS) MS01 trial

R. Stephens, M. Nankivell, M. Muers, 2007 .

Leukaemia and lymphoma among young people near Sellafield: Authors' reply

M. Gardner, M. Snee, 1990 .

Longstanding Challenges in Lung Cancer: Are We Meeting Them?

M. Snee, Matthew Hatton, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).